## KMI: Kinder Morgan, Inc. - XLE: Energy

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 2.22 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($26.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Enterprise Products Well-Positioned to Withstand Inflation Pressures**
- Source: The Globe and Mail | 20260102T191151 | Somewhat-Bullish | Relevance: 72%
- Enterprise Products Partners L.P. (EPD) is well-positioned to manage inflation due to its fee-based income from long-term, inflation-protected contracts for its midstream assets. The company anticipates additional predictable cash flow from key growth projects expected to be operational by late 2026. This resilient business model makes EPD an attractive option for income investors, similar to other midstream players like Kinder Morgan Inc. (KMI) and The Williams Companies, Inc. (WMB).

**2. Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today**
- Source: ts2.tech | 20251231T011008 | Somewhat-Bullish | Relevance: 64%
- Equinox Gold shares climbed approximately 2.2% as gold prices recovered from a recent selloff, with traders anticipating Federal Reserve minutes for clues on 2026 rate cuts. The company's stock movement is largely influenced by gold price fluctuations and interest rate expectations, despite recent news about its planned divestment of Brazil operations. Investors are also focused on the implications of the divestment on Equinox's future cost and production profile.

**3. Intuitive Surgical, Inc. $ISRG Shares Sold by Oak Asset Management LLC**
- Source: MarketBeat | 20251231T120818 | Neutral | Relevance: 64%
- Oak Asset Management LLC significantly reduced its stake in Intuitive Surgical (NASDAQ:ISRG) by 23.8% in Q3, now holding 5,685 shares valued at $2.543 million. This comes amid substantial insider selling, with company executives disposing of shares worth $63.53 million in the last 90 days. Despite the selling activity, Intuitive Surgical exceeded Q3 earnings expectations with $2.40 EPS and $2.51 billion in revenue, though the stock trades at a high P/E ratio of 75.7 and holds a "Moderate Buy" consensus rating from analysts.

**4. Calamos Advisors LLC Reduces Stock Holdings in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251231T095758 | Neutral | Relevance: 62%
- Calamos Advisors LLC reduced its stake in Intuitive Surgical, Inc. by 10.4% in the third quarter of 2025, selling 13,162 shares but still retaining 113,140 shares valued at approximately $50.6 million. Despite insider selling by corporate executives, Intuitive Surgical beat Q3 earnings estimates with $2.40 EPS and $2.51 billion in revenue, leading to a "Moderate Buy" consensus rating from analysts with an average target price of $611.08.

**5. Generate Investment Management Ltd Invests $5.59 Million in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251231T113651 | Neutral | Relevance: 62%
- Generate Investment Management Ltd initiated a new stake in Intuitive Surgical (NASDAQ:ISRG) during Q3, acquiring 12,500 shares valued at approximately $5.59 million. Intuitive Surgical reported strong Q3 earnings, beating analyst estimates with an EPS of $2.40 and revenue of $2.51 billion, a 22.9% year-over-year increase. Despite heavy institutional ownership, there have been recent insider dispositions, with insiders selling 114,007 shares worth about $63.53 million in the last 90 days.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Jefferies | $29 | $30 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Jefferies | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($26.08M) |
| Sells | 4 ($0.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 33.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.4%)
- Blackrock Inc.: 7.9% (+6.0%)
- State Street Corpora: 5.1% (-0.5%)
- JPMORGAN CHASE & CO: 2.9% (+83.5%)
- Geode Capital Manage: 2.4% (+2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Momentum building: MRS_20 improving +3.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.22 elevated, pricing in significant growth expectations. Forward P/E 20.0x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($26.1M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $61.6B |
| Beta | 0.67 |
| 52W Range | $23.94 - $31.48 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.22 |
| Forward P/E | 20.0 |
| Current P/E | 21.6 |
| YoY Growth | 7.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.2% to 2.9% (+3.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.91% (CS: 78) | Neutral |
| RSI_14 | 60.3 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.033x | Above |
| vs SMA200 | 1.014x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $27.71
- **Stop Loss:** $26.83 (3.2% risk)
- **Target:** $28.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1636
- **Position Value:** $45,333.56
- **Portfolio %:** 45.33%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-21 (Est: $0.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.30 | $0.29 | -2.8% |
| 2025Q2 | $0.28 | $0.28 | +0.8% |
| 2025Q1 | $0.36 | $0.34 | -4.8% |
| 2024Q4 | $0.33 | $0.32 | -2.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*